Drug Regulation
Rarely are congressional hearings due to a problem coming full circle. But recently Senator Grassley dragged executives from seven top pharmaceutical companies before a Senate Finance Committee hearing. Ostensibly he was trying to clear the “secrecy” behind how companies set prices. Lawmakers frequently call for increased transparency and legislative oversight of healthcare and especially pharmaceuticals. …
